Zum Hauptinhalt springen

Fentanyl

06. Oktober 2024 | Fentanyl

Peripheral opioid receptor antagonism alleviates fentanyl-induced cardiorespiratory depression and is devoid of aversive effects.

Peripheral opioid receptor antagonism alleviates fentanyl-induced cardiorespiratory depression and is devoid of aversive effects. Ruyle BC, Masud S, Kesaraju R, Tahirkheli M, Modh J, Angulo-Lopera S, Lintz T, Higginbotham JA, Massaly N, Mor...

06. Oktober 2024 | Fentanyl

How substance use preferences and practices relate to fentanyl exposure among people who use drugs in Rhode Island, USA.

How substance use preferences and practices relate to fentanyl exposure among people who use drugs in Rhode Island, USA. Shaw LC, Biello KB, Buxton JA, Goldman JE, Hadland SE, Sherman SG, Li Y, Macmadu A, Marshall BDL. Drug Alcohol D...

06. Oktober 2024 | Fentanyl

Fentanyl and Sudden Death-A Postmortem Perspective for Diagnosing and Predicting Risk.

Fentanyl and Sudden Death-A Postmortem Perspective for Diagnosing and Predicting Risk. Strenja I, Dadić-Hero E, Perković M, Šoša I. Diagnostics (Basel). 2024 Sep 9;14(17):1995. doi: 10.3390/diagnostics14171995. PMID: 39272779; PMCID:...

06. Oktober 2024 | Fentanyl

Correlates of fentanyl preference among people who use drugs in Rhode Island.

Correlates of fentanyl preference among people who use drugs in Rhode Island. Napoleon SC, Park CJ, Goldman J, Li Y, Buxton JA, Macmadu A, Biello KB, Noguchi J, Marshall BDL. Harm Reduct J. 2024 Sep 14;21(1):169. doi: 10.1186/s12954-...

06. Oktober 2024 | Fentanyl

Fentanyl-positive urine drug screens in the emergency department: Association with intentional opioid misuse and racial disparities.

Fentanyl-positive urine drug screens in the emergency department: Association with intentional opioid misuse and racial disparities. Shufflebarger EF, Reynolds LM, McNellage L, Booth JS, Brown J, Edwards AR, Li L, Robinett DA, Walter LA.&nb...

22. September 2024 | Fentanyl

What is the Transmucosal Immediate-Release Fentanyl (TIRF) REMS?

What is the Transmucosal Immediate-Release Fentanyl (TIRF) REMS? The Transmucosal Immediate Release Fentanyl (TIRF) Risk Evaluation and Mitigation Strategy (REMS) Program is an FDA-required program designed to ensure informed risk-benefit decisio...

10. September 2024 | Fentanyl

A qualitative evaluation of a fentanyl patch safer supply program in Vancouver, Canada. (2)

A qualitative evaluation of a fentanyl patch safer supply program in Vancouver, Canada. Norton A, Ivsins A, Holliday E, Sutherland C, Kerr T, Kennedy MC. Int J Drug Policy. 2024 Aug 17;131:104547. doi: 10.1016/j.drugpo.2024.104547. E...

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten